SERUM CARNITINE LEVELS IN EPILEPTIC CHILDREN BEFORE AND DURING TREATMENT WITH VALPROIC ACID, CARBAMAZEPINE, AND PHENOBARBITAL

Citation
M. Castrogago et al., SERUM CARNITINE LEVELS IN EPILEPTIC CHILDREN BEFORE AND DURING TREATMENT WITH VALPROIC ACID, CARBAMAZEPINE, AND PHENOBARBITAL, Journal of child neurology, 13(11), 1998, pp. 546-549
Citations number
26
Categorie Soggetti
Clinical Neurology",Pediatrics
Journal title
ISSN journal
08830738
Volume
13
Issue
11
Year of publication
1998
Pages
546 - 549
Database
ISI
SICI code
0883-0738(1998)13:11<546:SCLIEC>2.0.ZU;2-5
Abstract
Serum levels of free, acyl, and total carnitine were determined in 32 patients with seizures, before and after 3, 6, and 12 months of treatm ent with valproic acid (17 patients), carbamazepine (10 patients), or phenobarbital (5 patients). In all three treated groups, both free and total carnitine levels showed a significant decline with resp ect to pretreatment levels. This decline was most marked and most consistent in patients treated with valproic acid. In 35% of the patients in this group, carnitine deficiency (ie, total carnitine < 30 mu mol/L) was o bserved by month 12. In none of the three groups were serum carnitine levels significantly correlated with the serum concentration of the dr ug. These findings suggest a need to monitor serum carnitine levels in children treated with any of these drugs.